Cefiderocol Heteroresistance in NDM-Producing Enterobacterales: A Complex Polymicrobial Infection Successfully Salvaged With Ceftazidime-Avibactam Plus Aztreonam. [PDF]
Nuaimi M +6 more
europepmc +1 more source
Impact of Susceptibility Testing Methodology on the Positioning of Cefiderocol and Aztreonam-Avibactam Against Metallo-β-Lactamase-Producing Gram-Negative Bacteria. [PDF]
Del Nogal-Labrador F +7 more
europepmc +1 more source
Intrapulmonary penetration of ceftolozane/tazobactam and ceftazidime/avibactam administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial. [PDF]
Benítez-Cano A +15 more
europepmc +1 more source
Postsurgical infection with carbapenemase-producing Enterobacterales in a 45-year-old woman. [PDF]
Leung E, Fattouh R, Verway M, Tan C.
europepmc +1 more source
Comparison of the Efficacy and Safety of Intravenous Ceftazidime-Avibactam and Intrathecal/Intraventricular Polymyxin B Sulfate in the Treatment of CNS Infections Caused by KPC-<i>Kp</i> in Neurosurgical Patients: A Single-Center Prospective Observational Study. [PDF]
Wang MH +9 more
europepmc +1 more source
Reduced catalytic activity of KPC β-lactamase can increase ceftazidime resistance. [PDF]
Birgy A +7 more
europepmc +1 more source
Comparative <i>in vitro</i> efficacy of aztreonam-avibactam and other alternatives (cefepime-taniborbactam, cefepime-zidebactam, and cefiderocol) against metallo-β-lactamase-producing Enterobacterales isolated in 2024 in France. [PDF]
Emeraud C, Dutkiewicz M, Dortet L.
europepmc +1 more source
A multicenter performance evaluation of aztreonam-avibactam gradient diffusion susceptibility testing for <i>Enterobacterales</i>. [PDF]
Bui TI +7 more
europepmc +1 more source
Comparison of agar-based methodologies to broth disc elution for the detection of aztreonam susceptibility in the presence of ceftazidime-avibactam. [PDF]
Sandstrom TS +4 more
europepmc +1 more source
Spread of carbapenemase-producing <i>Serratia</i> spp. in France from 2016 to 2024: a comparative genomic study. [PDF]
Rezzoug I +8 more
europepmc +1 more source

